24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
10/06/2015
The Barcelona Synchrotron Park in the SmartReFlex European project
01/06/2015
SENER and ALBA sign a technology transfer agreement
28/05/2015
Synchrotron light applications for the pharmaceutical industry
20/05/2015
Financial Times ranks ESADE 7th worldwide in open executive education programmes
14/05/2015
Joint promotion in Korea of the Barcelona Synchrotron Park and the Parc Científic de Barcelona
07/05/2015
The UAB ranks well